Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patient Engagement In Clinical Trials Needs More FDA Guidance, Stakeholders Say

Executive Summary

Industry urges US FDA guidance on developing plain language summaries, which could help improve the release of clinical trial results to patients. 
Advertisement

Related Content

Clinical Trials: US FDA Should Frame Risk-Based Monitoring As Best Practice, ACRO Says
Pharma Requests Pilot To Test Public Value Of EU Guide On Plain Language Summaries

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124998

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel